Based on our combined results of PD-1 deficient/inhibitory mouse models and cytotoxicity assay, we propose a novel, direct role of ILC2-derived TNF-α in the apoptosis of B16 melanoma cells that is enhanced by anti-PD-1 therapy in the significant delay of melanoma tumor growth. The gene discussed is TNF; the disease is neoplasm.